Advances in drug development: Abiraterone: Current and future use in prostate cancer

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	180-181
Number of pages	2
Journal	Clinical Advances in Hematology and Oncology
Volume	10
Issue number	3
State	Published - Mar 1 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{838e578915d849fe8973104cb71d750e,

title = "Advances in drug development: Abiraterone: Current and future use in prostate cancer",

author = "Charles Ryan",

year = "2012",

month = mar,

day = "1",

language = "English (US)",

volume = "10",

pages = "180--181",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - Advances in drug development

T2 - Abiraterone: Current and future use in prostate cancer

AU - Ryan, Charles

PY - 2012/3/1

Y1 - 2012/3/1

UR - http://www.scopus.com/inward/record.url?scp=84858131077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858131077&partnerID=8YFLogxK

M3 - Article

C2 - 22402426

AN - SCOPUS:84858131077

SN - 1543-0790

VL - 10

SP - 180

EP - 181

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 3

ER -